Global healthcare 3D printing market will reach $12.75 billion by 2030, growing by 22.8% annually over 2020-2030 driven by technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 90 tables and 103 figures, this 191-page report “3D Printing in Healthcare: Global Market 2020-2030 by Component, Process and Technology, App...
North America healthcare 3D printing market is expected to grow by 21.6% annually in the forecast period and reach $5,003.8 million by 2030 driven by technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 31 tables and 67 figures, this 128-page report “3D Printing in Healthcare: North America Market 2020-2030 by Compo...
Europe healthcare 3D printing market accounted for $503.7 million in 2020 and will grow by 22.3% annually over 2020-2030 owing to the technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 41 tables and 71 figures, this 134-page report “3D Printing in Healthcare: Europe Market 2020-2030 by Component, Process and Techn...
Asia Pacific healthcare 3D printing market will grow by 25.0% annually with a total addressable market cap of $14.51 billion over 2020-2030 owing to the technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 38 tables and 70 figures, this 133-page report “3D Printing in Healthcare: Asia Pacific Market 2020-2030 by Com...
Global sports medicine market will reach $14.42 billion by 2030, growing by 6.6% annually over 2020-2030 driven by rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure. Highlighted with 91 tables and 88 figures, this 182-page report “Global Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User, and Region: Trend Forecast and Gr...
North America sports medicine market is expected to grow by 5.7% annually in the forecast period and reach $5,890.3 million by 2030 driven by rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure. Highlighted with 32 tables and 52 figures, this 120-page report “North America Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User,...
Europe sports medicine market accounted for $1,689.3 million in 2019 and will grow by 6.0% annually over 2020-2030 owing to the rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure. Highlighted with 42 tables and 56 figures, this 126-page report “Europe Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User, and Country: Trend F...
Asia Pacific sports medicine market will grow by 9.1% annually with a total addressable market cap of $23.25 billion over 2020-2030 owing to the rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure. Highlighted with 39 tables and 55 figures, this 125-page report “Asia Pacific Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End Use...
Global pharmaceutical CDMO market will reach $289.2 billion by 2030, growing by 6.9% annually over 2020-2030 driven by increasing demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures. Highlighted with 96 tables and 86 figures, this 194-page report “Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic App...
North America pharmaceutical CDMO market is expected to grow by 6.0% annually in the forecast period and reach $101.1 billion by 2030 driven by increasing demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures. Highlighted with 37 tables and 50 figures, this 131-page report “North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service ...
